Translational Research Cancer Centers Consortium (TRCCC) was initiated in 1998 to expedite the progress in immunotherapy and other biologic therapies. TRCCC has seen a steady growth in member cancer centers and annual meeting participants over the past decade. The organization has successfully brought together leaders in this field to advance science, collaboration and clinical trials to help individuals diagnosed with cancer. The annual TRCCC meeting also provides a unique opportunity for trainees to present and interact in a supportive environment.


TRCCC Goals


  • Present basic science and clinical research information related to tumor immunology and the use of other biological therapies
  • Serve to bring faculty, students, fellows and residents together from the region to share and exchange information
  • Facilitate implementation of clinical trials using immunotherapy and other biological therapies across the region.


Participating Members of TRCCC

About the Translational Research Cancer Centers Consortium

Copyright Translational Research Cancer Centers Consortium

Translational Research Cancer Centers Consortium

Expediting Progress in Cancer Immunotherapy

Translational Research Cancer Centers Consortium